- Home
- SCNI vs NIVF Comparison
SCNI vs NIVF Comparison
Compare SCNI & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- NIVF
- Stock Information
- Founded
- SCNI 2003
- NIVF 2011
- Country
- SCNI Israel
- NIVF Hong Kong
- Employees
- SCNI N/A
- NIVF N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- NIVF
- Sector
- SCNI Health Care
- NIVF
- Exchange
- SCNI Nasdaq
- NIVF NYSE
- Market Cap
- SCNI 1.9M
- NIVF 2.1M
- IPO Year
- SCNI N/A
- NIVF N/A
- Fundamental
- Price
- SCNI $2.76
- NIVF $3.52
- Analyst Decision
- SCNI
- NIVF
- Analyst Count
- SCNI 0
- NIVF 0
- Target Price
- SCNI N/A
- NIVF N/A
- AVG Volume (30 Days)
- SCNI 22.4K
- NIVF 300.9K
- Earning Date
- SCNI 07-01-2025
- NIVF 01-01-0001
- Dividend Yield
- SCNI N/A
- NIVF N/A
- EPS Growth
- SCNI N/A
- NIVF N/A
- EPS
- SCNI 5.95
- NIVF N/A
- Revenue
- SCNI $658,000.00
- NIVF $5,433,375.00
- Revenue This Year
- SCNI N/A
- NIVF N/A
- Revenue Next Year
- SCNI N/A
- NIVF N/A
- P/E Ratio
- SCNI $0.47
- NIVF N/A
- Revenue Growth
- SCNI N/A
- NIVF 5.79
- 52 Week Low
- SCNI $1.90
- NIVF $1.09
- 52 Week High
- SCNI $8.92
- NIVF $32.80
- Technical
- Relative Strength Index (RSI)
- SCNI 57.37
- NIVF 36.68
- Support Level
- SCNI $2.64
- NIVF $2.82
- Resistance Level
- SCNI $2.69
- NIVF $4.96
- Average True Range (ATR)
- SCNI 0.20
- NIVF 0.75
- MACD
- SCNI 0.09
- NIVF 0.28
- Stochastic Oscillator
- SCNI 88.24
- NIVF 17.65
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.